At AAIC 2022, Translucence Presented Their Work on Brain-Wide Measurement of Antibody Therapeutics, Microglia and β-Amyloid Plaques

Translucence Biosystems
August 3, 2022

Translucence Co-Founders Damian Wheeler, Ph.D. and Sunil Gandhi, Ph.D. along with their colleagues Chase Redd and Nathaniel Guanzon recently presented at the Alzheimer's Association International Conference® 2022. To help move AD drug discovery forward, Translucence has developed whole-brain regional assays for β-Amyloid plaques and microglia and with Lundbeck, methods to measure antibody therapeutics crossing the Blood-Brain Barrier and homing in on their target.

Access the "Brain Wide Monitoring of Antibody Therapeutics Crossing the Blood/Brain Barrier" poster here.

Access the "Brain-Wide Cellular Resolution Regional Quantification of Microglia and Amyloid in 5xfad Mice" poster here.

Ask your question

Send us your questions and we will get back to you as soon as possible

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

June 15, 2023

Highlights from the 9th Annual BRAIN Initiative Meeting

Translucence Biosystems recently participated in the 9th Annual BRAIN Initiative Meeting: Open Science, New Tools! The conference, held on June 12-13, 2023, aimed to foster a dynamic and collaborative research community through interactions among like-minded scientists who study the brain.
Angela Prvulovic
May 20, 2023

Co-Founder and CEO, Damian Wheeler Presents at KSNeurodegen23 on Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid

Co-Founder and CEO, Damian Wheeler, presented a poster titled "Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid" at the Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development conference hosted by the by Keystone Symposia on Molecular & Cellular Biology.
Angela Prvulovic
March 23, 2023

CEO, Damian Wheeler Ph.D., Presents at the BIO-SEE 2023 Webinar Series

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".
Translucence Biosystems